| Nicole Mugica, DO | |
|
890 Oak St Se, Salem, OR 97301-3905 | |
| (503) 814-7246 | |
| Not Available |
| Full Name | Nicole Mugica |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 7 Years |
| Location | 890 Oak St Se, Salem, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104352939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0002X | Internal Medicine - Hospice And Palliative Medicine | DO190354 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salem Hospital | Salem, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Salem Health | 8628986668 | 387 |
News Archive
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Cardiome Pharma Corp. announced the preliminary results of its modified "Dutch Auction" tender offer to purchase for cancellation up to US$27.5 million of its common shares (the "Offer"), which expired at 5:00 p.m. (Eastern time) on October 13, 2009.
The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.
› Verified 5 days ago
| Entity Name | Salem Health West Valley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245237486 PECOS PAC ID: 7810804630 Enrollment ID: O20040225000830 |
News Archive
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Cardiome Pharma Corp. announced the preliminary results of its modified "Dutch Auction" tender offer to purchase for cancellation up to US$27.5 million of its common shares (the "Offer"), which expired at 5:00 p.m. (Eastern time) on October 13, 2009.
The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.
› Verified 5 days ago
| Entity Name | Salem Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265431829 PECOS PAC ID: 8628986668 Enrollment ID: O20040309001131 |
News Archive
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Cardiome Pharma Corp. announced the preliminary results of its modified "Dutch Auction" tender offer to purchase for cancellation up to US$27.5 million of its common shares (the "Offer"), which expired at 5:00 p.m. (Eastern time) on October 13, 2009.
The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Mugica, DO 3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 Ph: (541) 768-4907 | Nicole Mugica, DO 890 Oak St Se, Salem, OR 97301-3905 Ph: (503) 814-7246 |
News Archive
Pharmacyclics, Inc. today announced results from a Phase II trial of the investigational oral agent ibrutinib which demonstrated rapid and sustained disease control as a monotherapy in untreated, relapsed and refractory chronic lymphocytic leukemia (CLL) patients, irrespective of characteristics that predict poor outcomes to chemoimmunotherapy.
In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Cardiome Pharma Corp. announced the preliminary results of its modified "Dutch Auction" tender offer to purchase for cancellation up to US$27.5 million of its common shares (the "Offer"), which expired at 5:00 p.m. (Eastern time) on October 13, 2009.
The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.
› Verified 5 days ago
Dr. Andrew P. Hope, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Suite 4000, Salem, OR 97301 Phone: 503-364-0189 Fax: 503-364-9288 | |
Brett W Mikeska, M D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560 | |
Dr. Aneet Jyot Deo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560 | |
Joseph J Thaler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5050 Skyline Village Loop S, Salem, OR 97306 Phone: 503-391-1110 Fax: 503-370-4237 | |
Dr. Krystyna Antonina Pekalska, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400 | |
Dr. Falguny I Bhavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Ste 3010, Salem, OR 97301 Phone: 503-399-7520 Fax: 503-362-7344 | |
Dr. Douglas Michael Carney, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 960 Liberty St Se Ste 140, Salem, OR 97302 Phone: 503-540-0304 Fax: 503-540-0305 |